Melanoma, Pediatric Oncology, Lymphoma & Plasma Cell Disorders Dominate Research Presentations from NYU Langone Medical Center at ASCO’s 2015 Conference

Epidemiology Studies Also Play a Prominent Role

NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), with researchers presenting close to 30 abstracts accepted for oral, poster, and publication presentations.    

Leading the way are eight oral abstract and poster presentations on melanoma for which an NYU Langone researcher is either a senior, lead, or contributing author. While many of these studies are multi-institutional, five poster presentations are led by the Perlmutter Cancer Center’s Interdisciplinary Melanoma Cooperative Group.  These include:

Spearheading NYU Langone’s presentations of melanoma clinical trials presented at ASCO 2015 are:

  • Anna C. Pavlick, DO, Associate Professor, Department of Medicine, Division of Medical Oncology, and the Ronald O. Perelman Department of Dermatology, and Medical Director of the Clinical Trials Office at the Perlmutter Cancer Center;
  • Iman Osman, MD, Associate Professor, Departments of Dermatology, Urology and Medicine, and Associate Director of the Perlmutter Cancer Center and Director of its Interdisciplinary Melanoma Cooperative Group (IMCG);
  • David Polsky, MD, PhD, The Alfred W. Kopf, MD Professor of Dermatologic Oncology and the Director of the Pigmented lesion Service, Ronald O. Perelman Department of Dermatology, Professor in the Department of Pathology, and a member of the IMCG; and
  • Tomas Kirchhoff, PhD, Assistant Professor, Department of Population Health, Division of Epidemiology, and a member of the IMCG.

NYU Langone also will be part of several oral abstract and poster presentations by the Children’s Oncology Group on the topics of B-lymphoblastic leukemia and acute lymphoblastic leukemia. William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics and Director of the Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders at NYU Langone, will be presenting as part of an education session entitled Real-Time Molecular Genetic Profiling: The Future is Now (Or is It?). Dr. Carroll will present a study entitled State-of-the-Art Discovery with Tumor Profiling in Pediatric Oncology.  

In addition, Dr. Carroll is represented as a co-investigator in the following presentations:

Lymphoma and plasma cell disorders are the focus of other sessions, at which NYU Langone and its Perlmutter Cancer Center will be well represented. Catherine S. Diefenbach, MD, Assistant Professor of Medicine, Division of Medical Oncology, will lead the following poster presentation:

In addition, Dr. Diefenbach has contributed to other oral abstract and poster presentations, including:

Two NYU Langone-led epidemiologic studies, for which Stephanie V. Blank, MD, Associate Professor, Department of Obstetrics & Gynecology, serves as senior author, also will be presented at ASCO 2015:

“Our clinical and research community is proud that so many of our colleagues will be presenting and involved in ASCO 2015,” said Benjamin G. Neel, MD, PhD, Director of the Perlmutter Cancer Center at NYU Langone. “What is most impressive is that our research covers a diverse array of topics, all of them critical areas in which we hope to lead further research into improving diagnosis, treatment and outcomes.”

Media Inquiries:

Jim Mandler
Phone: 212-404-3525
jim.mandler@nyumc.org